Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.

Lofgren KA, Ostrander JH, Housa D, Hubbard GK, Locatelli A, Bliss RL, Schwertfeger KL, Lange CA.

Breast Cancer Res. 2011 Sep 17;13(5):R89. doi: 10.1186/bcr2946.

2.

Brk/PTK6 signaling in normal and cancer cell models.

Ostrander JH, Daniel AR, Lange CA.

Curr Opin Pharmacol. 2010 Dec;10(6):662-9. doi: 10.1016/j.coph.2010.08.007. Epub 2010 Sep 9. Review.

3.

Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.

Brauer PM, Tyner AL.

Biochim Biophys Acta. 2010 Aug;1806(1):66-73. doi: 10.1016/j.bbcan.2010.02.003. Epub 2010 Feb 26. Review.

4.

A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.

Stein T, Salomonis N, Nuyten DS, van de Vijver MJ, Gusterson BA.

J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):99-116. doi: 10.1007/s10911-009-9120-1. Epub 2009 Apr 30. Review. Erratum in: J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):117-9.

PMID:
19408105
5.

Tracing the footprints of the breast cancer oncogene BRK - Past till present.

Goel RK, Lukong KE.

Biochim Biophys Acta. 2015 Aug;1856(1):39-54. doi: 10.1016/j.bbcan.2015.05.001. Epub 2015 May 18. Review.

PMID:
25999240
6.

The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3.

Chapman RS, Lourenco P, Tonner E, Flint D, Selbert S, Takeda K, Akira S, Clarke AR, Watson CJ.

Adv Exp Med Biol. 2000;480:129-38. Review.

PMID:
10959419
7.
8.

Noncanonical TGF-β signaling during mammary tumorigenesis.

Parvani JG, Taylor MA, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):127-46. doi: 10.1007/s10911-011-9207-3. Epub 2011 Mar 31. Review.

9.

Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Locatelli A, Lofgren KA, Daniel AR, Castro NE, Lange CA.

Horm Cancer. 2012 Apr;3(1-2):14-25. doi: 10.1007/s12672-011-0097-z. Review.

10.

Mammary involution and breast cancer risk: transgenic models and clinical studies.

Radisky DC, Hartmann LC.

J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):181-91. doi: 10.1007/s10911-009-9123-y. Epub 2009 Apr 30. Review.

11.

ErbB/EGF signaling and EMT in mammary development and breast cancer.

Hardy KM, Booth BW, Hendrix MJ, Salomon DS, Strizzi L.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):191-9. doi: 10.1007/s10911-010-9172-2. Epub 2010 Apr 6. Review.

12.

Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.

Furth PA, Nakles RE, Millman S, Diaz-Cruz ES, Cabrera MC.

Breast Cancer Res. 2011 Oct 12;13(5):220. doi: 10.1186/bcr2921. Review.

13.
14.

Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.

Zheng Y, Tyner AL.

Eur J Clin Invest. 2013 Apr;43(4):397-404. doi: 10.1111/eci.12050. Epub 2013 Feb 10. Review.

15.

STAT signaling in mammary gland differentiation, cell survival and tumorigenesis.

Haricharan S, Li Y.

Mol Cell Endocrinol. 2014 Jan 25;382(1):560-9. doi: 10.1016/j.mce.2013.03.014. Epub 2013 Mar 28. Review.

16.

Hedgehog signaling in the normal and neoplastic mammary gland.

Visbal AP, Lewis MT.

Curr Drug Targets. 2010 Sep;11(9):1103-11. Review.

PMID:
20545610
17.

Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.

Goel RK, Lukong KE.

Cancer Metastasis Rev. 2016 Jun;35(2):179-99. doi: 10.1007/s10555-016-9623-3. Review.

PMID:
27067725
18.

β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer.

Lahlou H, Muller WJ.

Breast Cancer Res. 2011;13(6):229. doi: 10.1186/bcr2905. Epub 2011 Nov 30. Review.

19.

The Stat3 paradox: a killer and an oncogene.

Resemann HK, Watson CJ, Lloyd-Lewis B.

Mol Cell Endocrinol. 2014 Jan 25;382(1):603-11. doi: 10.1016/j.mce.2013.06.029. Epub 2013 Jul 1. Review.

PMID:
23827176
20.

RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.

Brauer PM, Tyner AL.

Cell Cycle. 2009 Sep 1;8(17):2728-32. Epub 2009 Sep 29. Review.

Supplemental Content

Support Center